MA-EXCEL-DRYER
29.8.2016 21:47:37 CEST | Business Wire | Press release
Excel Dryer, Inc. , creator of the high-speed, energy-efficient hand dryer category that revolutionized the industry, today announced the publication of the industry’s first dry time and energy use results in compliance with the first global Product Category Rule (PCR) published by UL Environment (a business division of Underwriters’ Laboratories). SGS, the world’s leading inspection, verification, testing and certification company was selected by Excel Dryer to test the XLERATOR Hand Dryer models. The original, patented, high-speed, energy-efficient XLERATOR® Hand Dryer recorded an 8 second* dry time and 3.7 Wh* of energy per use while the XLERATOReco ® Hand Dryer recorded 10 seconds*, 1.7 Wh*, respectively, making them the first-published in the industry.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160829005943/en/
PCRs are the first step toward the development of Environmental Product Declarations (EPDs), type III, independently verified ecolabels that govern one or more product categories. A PCR is a set of rules, requirements and guidelines following internationally established standards that make it easier to consistently evaluate products’ environmental impacts. The publication of the global hand dryer PCR is the culmination of more than a year long, data-driven and science-backed process and is the first testing method for hand dryers established through industry consensus. Standardized evaluation guidelines and reporting allow for the specifying community and buyers to conduct a more ‘apples-to-apples’ comparison of hand dryers, and ultimately make a more informed decision, based on credible third-party testing and not false claims.
“We are proud to have initiated the development of the first-ever global PCR published by UL Environment,” said Vice President of Marketing at Excel Dryer, William Gagnon, who also served as Chairman of the PCR Project. “Excel Dryer recognized the need to standardize the way products are evaluated by the hand dryer industry on a global scale. This PCR includes testing guidelines established through industry consensus that specify how a hand dryer’s performance is tested for energy use and dry times, both key components to properly reporting their environmental impact. Third-party testing to these guidelines levels the playing field and ushers the hand dryer industry into a new ‘age of transparency.’”
“If we say something, we can back it up,” said Excel Dryer President, Denis Gagnon. “I’m proud to be an American manufacturer of quality products people enjoy using and can depend on. The publication of the first-ever global PCR allows companies to create EPDs which help people compare hand dryers accurately to make a better decision. We make the best hand dryers in the industry and these results prove it.”
The hand dryer market, like so many others, is inundated with knockoff products and manufacturers making unsubstantiated claims. Architects and specifiers may approve ‘or equal’ products that are not true equivalents. The same is true for buyers looking to compare and purchase the best product for their facilities. All products need to be evaluated by the same set of rules and reporting guidelines — for hand dryers, that rule is the new, global PCR from UL Environment.
For more information about Excel Dryer or its product line, visit exceldryer.com . To learn more about the new, global PCR visit exceldryer.com/pcr .
About Excel Dryer, Inc. For over 50 years, Excel Dryer has been manufacturing the finest American made hand dryers featuring the XLERATOR ® Hand Dryer. Excel Dryer is a family-owned and –operated company which revolutionized the industry by inventing the patented XLERATOR technology that created the high-speed, energy-efficient hand dryer category and set a new standard for performance, reliability and customer satisfaction. Excel Dryer continues to lead the industry with its expanded and enhanced product line featuring adjustable speed and sound, HEPA Filtration System, adjustable heat settings, multi-voltage options and more. Combined with the most complete line of options and accessories, the best hand drying solution can be designed for any restroom environment. Excel Dryer prides itself on offering the ultimate customer service and making dependable products by employees committed to quality and dependability. Excel Dryer products are available through an established network of sales representatives who call on more than 4,000 distributors globally for distribution worldwide. Learn more about Excel Dryer at exceldryer.com .
* Dry time and energy use testing performed by SGS International on standard XLERATOR/XLERATOReco Hand Dryers with 0.8" nozzle to 0.25g or less of residual moisture, pursuant to the UL Environment Global Product Category Rules (PCR) for Hand Dryers.
About SGS The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With more than 85,000 employees, SGS operates a network of over 1,800 offices and laboratories around the world.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160829005943/en/
Contact:
For Excel Dryer, Inc.
Caroline Lee or
Michelle Abdow
(Office) 413-787-1133
(Cell) 630-926-4537
Caroline@marketmentors.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom